Marksans Pharma Ltd has completed the acquisition of 100% share capital of Germany-based ABCNow GmbH. The company finalized the transaction on July 20, 2026, expanding its international footprint through this strategic move.

The acquisition was disclosed to the stock exchanges under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory filing confirms that the process to acquire the entire share capital of the German entity has been concluded.

Acquisition Details

The following table summarises the key details of the completed transaction:

The completion of this acquisition marks a significant development for Marksans Pharma as it integrates the new subsidiary into its operations. The company had initially intimated the exchanges about the proposed acquisition on July 8, 2026.

Marksans Pharma Ltd has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH for a total cash consideration of €892,384. The acquisition is a strategic move to expand Marksans Pharma's presence across regulated European markets by securing direct, owned market-access capabilities in the European Union. The transaction is expected to be completed by July 31, 2026.

ABCnow GmbH is a pharmaceutical wholesale and distribution company headquartered in Flensburg, Germany. It is primarily engaged in the marketing and distribution of over-the-counter (OTC) products in the German healthcare market. The target entity was incorporated in 2023 and achieved revenue of €510,215.60 in 2024 and €227,233.69 in 2025.

The acquisition will enable Marksans Pharma to utilize ABCnow GmbH's front-end sales and marketing infrastructure to market products manufactured in its India, UK, and USA regions. This integration is designed to bolster the company's presence in European markets and support its growth aspirations through a capable team of professionals in Germany.

The transaction involves a cash consideration and does not constitute a related party transaction. The shareholders of ABCnow GmbH are not related to Marksans Pharma, and the promoter or promoter group of the company holds no interest in the entity being acquired. No governmental or regulatory approvals are required for the completion of this acquisition.

Key Details of ABCnow GmbH